Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-003324-19Phase 4Completed
Phase 4, randomised trial in Focal Onset Epilepsy comparing Levetiracetam, Lamotrigine and Carbamazepine slow release (3 arms). Primary endpoint: Retention rate at 58 weeks. Started Sep 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-003324-19.